KIA
ONC

Knollwood Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Knollwood Investment Advisory’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Hold
1,111
– – 0.03% 256
2025
Q4 		$338K Hold
1,111
– – 0.03% 269
2025
Q3 		$379K Sell
1,111
-39
-3% -$11.8K 0.03% 285
2025
Q2 		$278K Hold
1,150
– – 0.03% 316
2025
Q1 		$313K Hold
1,150
– – 0.03% 303
2024
Q4 		$212K Hold
1,150
– – 0.02% 345
2024
Q3 		$258K Buy
+1,150
New +$207K 0.03% 332

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Knollwood Investment Advisory's ONC Position: Q1 2026 in Review

Knollwood Investment Advisory held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 1,111 shares worth $330K. The position accounts for 0.03% of the portfolio, ranked #256.

Knollwood Investment Advisory first reported a position in ONC in Q3 2024 and has held it in 7 quarters since. The position peaked at $379K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Knollwood Investment Advisory held 1,111 shares of BeOne Medicines Ltd worth $330K as of Q1 2026.
  • Knollwood Investment Advisory left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up 0.03% of Knollwood Investment Advisory's portfolio in Q1 2026, its #256 holding.
  • Knollwood Investment Advisory first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 7 quarters since.
  • Knollwood Investment Advisory's BeOne Medicines Ltd position peaked at $379K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.